← Back to Clinical Trials
Recruiting NCT05841732

NCT05841732 MyBack - A Behavior Change Informed Exercise Program to Prevent Low Back Pain Recurrences

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05841732
Status Recruiting
Phase
Sponsor Instituto Politécnico de Setúbal
Condition Low Back Pain
Study Type INTERVENTIONAL
Enrollment 186 participants
Start Date 2023-04-10
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Usual CareMyBack Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 186 participants in total. It began in 2023-04-10 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Low Back Pain is a common heath condition with high rates of recurrence and huge associated costs. Research has focused its efforts on analysing the effects of interventions while knowledge about effective secondary prevention strategies is limited. MyBack study aims to analyse the effectiveness of a tailored exercise and behavioural change program (MyBack program) in the secondary prevention of low back pain, and evaluate acceptability, feasibility and determinants of implementation by the different stakeholders, as well as the implementation strategy of the MyBack program, through a hybrid type I, randomized, controlled and multicentre study of effectiveness and implementation in the context of primary health care.

Eligibility Criteria

Inclusion Criteria: * Recovered (within the last 3 months) from an episode of non-specific LBP (with or without leg pain and of any duration) * Recovery from an LBP episode is defined as having a pain score of "0" or "1" on a 11-point Numeric Pain Rating Scale for, at least, 30 consecutive days * Age between 18 and 65 years; * Read and speak the Portuguese language; * Having a mobile phone capable of receiving and sending text messages; * No medical contraindication to exercise. Exclusion Criteria: * Diagnosis, or symptoms consistent with, severe depression or other psychiatric condition, * Pregnancy * Spinal surgery in the last 6 months

Contact & Investigator

Central Contact

Eduardo Cruz, PhD

✉ eduardo.cruz@ess.ips.pt

📞 +365 265 709 300

Principal Investigator

Eduardo Cruz, PhD

PRINCIPAL INVESTIGATOR

Instituto Politécnico de Setúbal

Frequently Asked Questions

Who can join the NCT05841732 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05841732 currently recruiting?

Yes, NCT05841732 is actively recruiting participants. Contact the research team at eduardo.cruz@ess.ips.pt for enrollment information.

Where is the NCT05841732 trial being conducted?

This trial is being conducted at Setúbal, Portugal.

Who is sponsoring the NCT05841732 clinical trial?

NCT05841732 is sponsored by Instituto Politécnico de Setúbal. The principal investigator is Eduardo Cruz, PhD at Instituto Politécnico de Setúbal. The trial plans to enroll 186 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology